An Analysis of the Presentations of Rhino-Orbital Mucormycosis Amidst the COVID Pandemic: A Case Series Report

dc.contributor.authorShah, Kintu Sen_US
dc.contributor.authorBhatt, Jineel Ben_US
dc.contributor.authorRawal, Reema Men_US
dc.contributor.authorDohadwala, Zainab Sen_US
dc.contributor.authorShah, Shailjaa Nen_US
dc.contributor.authorPatel, Kinjal Gen_US
dc.date.accessioned2024-09-24T08:06:45Z
dc.date.available2024-09-24T08:06:45Z
dc.date.issued2023-03
dc.description.abstractMucormycosis infection is caused by a group of filamentous molds belonging to the order Mucorales. Source of infection maybe inhalation of spores, contaminated food or inoculation into cut skin or open wounds. In developed countries, mucormycosis occurs primarily in severely immunocompromised hosts (e.g. those with hematological malignancies, organ transplantation, neutropenia, autoimmune disorders or other impairments in immunity). More than 100 cases of mucormycosis in people with COVID-19 have been reported, of which 4 of 5 cases were from India and others from the rest of the world. COVID-19 being an immunocompromising condition and steroids being an important part of therapy led to increasing number of cases of rhino-orbital mucormycosis. Our aim is study ocular presentation of the disease amidst COVID-19 peak.Materials and methods: COVID-19 patients (primary and referral) of rhino-orbital mucormycosis reaching a tertiary health care institute of Ahmedabad were diagnosed via clinical microbiological and radiological tests and evaluated. Vision, ocular movements and slit lamp bio-microscopy of conscious ambulatory patients, bed side examination of critical patients and detailed retinal evaluation of all the patients was done. Systemic comorbidities were noted and diabetic profile was done.Results and conclusions: Following findings were noted: Lid edema (n=30, 100%), profound vision loss (n=21, 73.33%), ophthalmoplegia (n=26, 86.67%), arterial occlusion (n=16, 60%), Ptosis (n=16, 60%), chemosis (=16, 60%), proptosis (n=16, 60%), Congestion (n=9, 33.33%). Thus, these are the signs to look out for in patients admitted for COVID-19 disease.en_US
dc.identifier.affiliationsDepartment of Ophthalmology, C.H. Nagri Eye Hospital, Ellisbridge, Ahmedabad, Indiaen_US
dc.identifier.affiliationsDepartment of Ophthalmology, C.H. Nagri Eye Hospital, Ellisbridge, Ahmedabad, Indiaen_US
dc.identifier.affiliationsDepartment of Ophthalmology, C.H. Nagri Eye Hospital, Ellisbridge, Ahmedabad, Indiaen_US
dc.identifier.affiliationsDepartment of Ophthalmology, C.H. Nagri Eye Hospital, Ellisbridge, Ahmedabad, Indiaen_US
dc.identifier.affiliationsDepartment of Ophthalmology, C.H. Nagri Eye Hospital, Ellisbridge, Ahmedabad, Indiaen_US
dc.identifier.affiliationsDepartment of Ophthalmology, C.H. Nagri Eye Hospital, Ellisbridge, Ahmedabad, Indiaen_US
dc.identifier.citationShah Kintu S, Bhatt Jineel B, Rawal Reema M, Dohadwala Zainab S, Shah Shailjaa N, Patel Kinjal G. An Analysis of the Presentations of Rhino-Orbital Mucormycosis Amidst the COVID Pandemic: A Case Series Report. International Journal of Medical Research & Health Sciences. 2023 Mar; 12(3): 1-4en_US
dc.identifier.issn2319-5886
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/230951
dc.languageenen_US
dc.publisherSumathi Publicationsen_US
dc.relation.issuenumber3en_US
dc.relation.volume12en_US
dc.source.urihttps://www.ijmrhs.com/medical-research/an-analysis-of-the-presentations-of-rhinoorbital-mucormycosis-amidst-the-covid-pandemic-a-case-series-report-96421.htmlen_US
dc.subjectMucormycosisen_US
dc.subjectCOVID-19en_US
dc.subjectImmunocompromiseden_US
dc.subjectDiabetes mellitusen_US
dc.subjectArterial occlusionen_US
dc.titleAn Analysis of the Presentations of Rhino-Orbital Mucormycosis Amidst the COVID Pandemic: A Case Series Reporten_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
ijmrhs2023v12n3p1E.pdf
Size:
714.35 KB
Format:
Adobe Portable Document Format